US Stock MarketDetailed Quotes

NAVB Navidea Biopharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 26 16:00 ET
10.01KMarket Cap0.00P/E (TTM)

About Navidea Biopharmaceuticals Company

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Company Profile

SymbolNAVB
Company NameNavidea Biopharmaceuticals
Listing DateFeb 10, 2011
Issue Price6.00
Founded1983
CEODr. Michael S. Rosol, PhD
MarketPink Market
Employees15
Fiscal Year Ends12-31
Address4995 Bradenton Avenue,Suite 240
CityDublin
ProvinceOhio
CountryUnited States of America
Zip Code43017-3552
Phone1-614-793-7500

Company Executives

  • Name
  • Position
  • Salary
  • Craig Dais
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • John K. Scott, Jr
  • Vice Chairman of the Board
  • 110.15K
  • Dr. Jill Bieker Stefanelli, PhD
  • Director
  • --
  • Joshua M. Wilson
  • Director
  • 17.72K
  • Dana J. Moss, J.D.
  • Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.